Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-979-6 | CAS number: 1070-70-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
There are no studies available assessing the absorption or metabolism of1,4-butanediyl diacrylate (BDDA).BDDA is a water clear, colorless liquid at 20 °C. It has a molecular weight of 198 g/mol, a vapor pressure of 0.00422 hPa (at 20°C), a log pow of 1.9 (at 23°C), and a water solubility of 3.1 g/l.
Oral absorption
Absorption is a property of a substance to cross biological membranes. Generally, oral absorption is favored for molecular weights below 500 g/mol and log Pow values between -1 and 4. Therefore, BDDA with a molecular weight of 198 g/mol and a log pow of 1.9 most likely diffuses very well across intestinal membranes. Furthermore, in a subacute oral toxicity study, rats were administered 20-200 mg/kg bw BDDA by gavage once daily [1]. The adjusted liver weights for males receiving Laromer BDDA at 200 mg/kg/day killed after 5 weeks of treatment were significantly increased compared to the control values. This change was considered adaptive and as a consequence of increased metabolic activity. Meaning altogether, there’s given proof for intestinal uptake of BDDA.
Dermal absorption
Liquids, like BDDA, and substances in solution are taken up more readily than dry particulates via dermal absorption. In general, dermal absorption is favored by small molecular weights and high water-solubility of the substance. Log Pow values between 1 and 4 favor dermal absorption, particularly if water solubility is high. The high water-solubility of 3.1 g/l together with the log pow of 1.9 of BDDA are conferred with a high dermal uptake. Additionally, in an acute dermal toxicity study dose levels of 400-2000 mg/kg bw BDDA were administered to rats [2]. Mortality, unsteady breathing, apathy and staggering were observed, indicating bioavailability of BDDA also via the dermal route. But it must be considered, that effects overserved were possibly induced by the irritating potential of BDDA and are therefore possibly no systemic effects.
Inhalation absorption
Absorption via the respiratory route also depends on physico-chemical properties like vapor pressure, log Pow and water solubility. BDDA has a low vapor pressure of 4.22 Pa at 20°C. Therefore, inhalation of vapor of the respective substance is very unlikely to occur. Theoretically, if inhalation of the substance occurred during handling, BDDA might be dissolved in the mucus of the respiratory tract due to its high water-solubility (3.1 g/l). Absorption directly across the respiratory tract epithelium by passive diffusion is also possible. Additionally, in a standardized inhalation hazard test with a saturated vapor atmosphere, more than half of the rats died after 1, 3 and 8 h exposure respectively [3], indicating a bioavailability of BDDA also via the inhalation route. But it must be considered, that effects overserved were possibly induced by the irritating potential of BDDA and are therefore possibly no systemic effects.
Based on the results of the described toxicity studies, an indication of oral, dermal or inhalation uptake of BDDA is given. Therefore, bioavailability can be considered to be existent.
Metabolism
Considering the chemical structure of BDDA, metabolism may consist of epoxidation of the acrylic double bond and subsequent hydrolysis and GSH conjugation, or of an oxidation at the C terminus to the acid followed by ß-oxidation involving degradation of the alkyl chain, or of an ester hydrolysis leading to the release of acrylic acid.
Accumulation
Taking into account the log Pow (1.9), the water solubility (3.1 g/l) and the considerations on the metabolism, accumulation of BDDA is considered to be unlikely.
Excretion
BDDA is very easily metabolized yielding small and water soluble metabolites. Due to their respective molecular weights below 300 and their respective water solubility, unmetabolized leftover-BDDA and its metabolites are most likely excreted via urine.
References
[1] BASF study on repeated dose toxicity in rats no. 85R0376/06X087, 2018
[2] BASF study on acute oral and dermal toxicity in rats no. 78/279, 1979
[3] BASF study on acute inhalative toxicity in rats no. XIII/160, 1963
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.